Hironari Tamiya

859 total citations
53 papers, 586 citations indexed

About

Hironari Tamiya is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hironari Tamiya has authored 53 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 13 papers in Surgery. Recurrent topics in Hironari Tamiya's work include Sarcoma Diagnosis and Treatment (25 papers), Vascular Tumors and Angiosarcomas (12 papers) and Cardiac tumors and thrombi (10 papers). Hironari Tamiya is often cited by papers focused on Sarcoma Diagnosis and Treatment (25 papers), Vascular Tumors and Angiosarcomas (12 papers) and Cardiac tumors and thrombi (10 papers). Hironari Tamiya collaborates with scholars based in Japan, Israel and United States. Hironari Tamiya's co-authors include Heejung Kim, Hyungsoo Kim, Ze’ev A. Ronai, Yan Li, Yongmei Feng, Yoshinori Imura, Toru Wakamatsu, Satoshi Takenaka, Norifumi Naka and Kazuhiro Iwaï and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hironari Tamiya

44 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hironari Tamiya Japan 12 308 218 160 120 94 53 586
Tetsuhiro Nakano Japan 13 263 0.9× 189 0.9× 202 1.3× 57 0.5× 65 0.7× 30 529
Rongqun Guo China 13 258 0.8× 171 0.8× 88 0.6× 253 2.1× 103 1.1× 22 635
Shifeng Mao United States 13 398 1.3× 174 0.8× 96 0.6× 208 1.7× 89 0.9× 37 705
Victor Kwan Min Lee Singapore 12 202 0.7× 201 0.9× 114 0.7× 49 0.4× 87 0.9× 43 511
Kazunobu Sueyoshi Japan 12 322 1.0× 263 1.2× 101 0.6× 149 1.2× 123 1.3× 34 716
M. Morell Spain 13 282 0.9× 231 1.1× 73 0.5× 33 0.3× 171 1.8× 25 569
Preeti Narayan United States 9 155 0.5× 248 1.1× 85 0.5× 105 0.9× 87 0.9× 18 497
Jeremy Rosenblum United States 10 129 0.4× 142 0.7× 140 0.9× 73 0.6× 72 0.8× 29 351
Iris Halbwedl Austria 15 133 0.4× 187 0.9× 309 1.9× 32 0.3× 98 1.0× 23 542
Sebastian Kłosek Poland 10 168 0.5× 129 0.6× 71 0.4× 54 0.5× 101 1.1× 20 474

Countries citing papers authored by Hironari Tamiya

Since Specialization
Citations

This map shows the geographic impact of Hironari Tamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hironari Tamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hironari Tamiya more than expected).

Fields of papers citing papers by Hironari Tamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hironari Tamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hironari Tamiya. The network helps show where Hironari Tamiya may publish in the future.

Co-authorship network of co-authors of Hironari Tamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Hironari Tamiya. A scholar is included among the top collaborators of Hironari Tamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hironari Tamiya. Hironari Tamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamiya, Hironari, Kazumi Nishino, Yuji Kato, et al.. (2025). Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types. Current Oncology. 32(1). 42–42.
2.
Yamada, Yoshiki, Toru Wakamatsu, Yoshinori Imura, et al.. (2024). Efficacy of surgery in the management of multiple recurrences of retroperitoneal dedifferentiated liposarcoma. World Journal of Surgical Oncology. 22(1). 265–265. 1 indexed citations
3.
Hasei, Joe, Ryuichi Nakahara, Yujiro Otsuka, et al.. (2024). The Three-Class Annotation Method Improves the AI Detection of Early-Stage Osteosarcoma on Plain Radiographs: A Novel Approach for Rare Cancer Diagnosis. Cancers. 17(1). 29–29. 2 indexed citations
4.
Yoshida, Kenichi, Rie Suzuki, Yoshinori Imura, et al.. (2024). Successful pazopanib treatment of undifferentiated pleomorphic sarcoma with coamplification of PDGFRA, VEGFR2 and KIT: A case report. Molecular and Clinical Oncology. 21(4). 69–69. 1 indexed citations
5.
Tamiya, Hironari, et al.. (2024). Physical function assessment scales used in rehabilitation for upper limb lymphedema: a scoping review. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations
6.
Nakamura, Tomoki, Satoshi Takenaka, Hidetatsu Outani, et al.. (2024). The Combined Use of Inflammation Markers, Modified Glasgow Prognostic Score, and Sarculator Nomogram in Extremity Soft Tissue Sarcoma: A Multicenter Observational Study. Cancers. 16(5). 1077–1077. 2 indexed citations
7.
Tamiya, Hironari, et al.. (2023). SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction. Cancers. 15(13). 3484–3484. 5 indexed citations
8.
Kato, Yuji, et al.. (2023). Intra- and inter-rater reliabilities of skin mechanical properties measured in healthy individuals using skin elasticity meter. Annals of Medicine. 55(2). 2279747–2279747. 3 indexed citations
9.
Tamiya, Hironari, Yoshinori Imura, Toru Wakamatsu, & Satoshi Takenaka. (2022). Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma. Journal of Geriatric Oncology. 13(5). 673–681. 3 indexed citations
10.
Imura, Yoshinori, Hidetatsu Outani, Satoshi Takenaka, et al.. (2021). Clinical Outcomes and Prognostic Factors for Patients with Malignant Peripheral Nerve Sheath Tumour. Sarcoma. 2021. 1–9. 3 indexed citations
11.
Kawai, Akira, Norifumi Naka, Akihiko Shimomura, et al.. (2021). Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study. Investigational New Drugs. 39(6). 1559–1567. 7 indexed citations
12.
Kim, Hyungsoo, Hyungsoo Kim, Heejung Kim, et al.. (2020). PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science Translational Medicine. 12(551). 167 indexed citations
13.
Yagi, Toshinari, Shigenori Nagata, Takashi Yamamoto, et al.. (2020). Malignant gastrointestinal neuroectodermal tumor with BRAF mutation and a history of malignant melanoma: A case report. Molecular and Clinical Oncology. 14(2). 23–23. 5 indexed citations
14.
Outani, Hidetatsu, Satoshi Takenaka, Kenichiro Hamada, et al.. (2020). A long‐term follow‐up study of extracorporeal irradiated autografts in limb salvage surgery for malignant bone and soft tissue tumors: A minimum follow‐up of 10 years after surgery. Journal of Surgical Oncology. 121(8). 1276–1282. 13 indexed citations
15.
Tamiya, Hironari, et al.. (2020). Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma. SHILAP Revista de lepidopterología. 2020. 1–7.
16.
Tamiya, Hironari, Yoshinori Imura, Takaaki Nakai, et al.. (2019). Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling. Molecular Cancer Therapeutics. 19(3). 742–754. 13 indexed citations
17.
Outani, Hidetatsu, Shigeki Kakunaga, Kenichiro Hamada, et al.. (2019). Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy. Molecular and Clinical Oncology. 11(2). 151–156. 3 indexed citations
18.
Tamiya, Hironari, Hyungsoo Kim, Heejung Kim, et al.. (2017). SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth. Journal of Clinical Investigation. 128(1). 517–530. 33 indexed citations
19.
Nakai, Takaaki, Yoshinori Imura, Hironari Tamiya, et al.. (2017). Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma. Cancer Medicine. 6(9). 2121–2130. 12 indexed citations
20.
Miki, Yukio, Takuhito Tada, Makoto Hosono, et al.. (2013). Single institutional experience of the treatment of angiosarcoma of the face and scalp. British Journal of Radiology. 86(1030). 20130439–20130439. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuhiro Nakano Breakdown of academic impact, for papers by Rongqun Guo Breakdown of academic impact, for papers by Shifeng Mao Breakdown of academic impact, for papers by Victor Kwan Min Lee Breakdown of academic impact, for papers by Kazunobu Sueyoshi Breakdown of academic impact, for papers by M. Morell Breakdown of academic impact, for papers by Preeti Narayan Breakdown of academic impact, for papers by Jeremy Rosenblum Breakdown of academic impact, for papers by Iris Halbwedl Breakdown of academic impact, for papers by Sebastian Kłosek
Rankless by CCL
2026